These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Relationship between β-Secretase, inflammation and core cerebrospinal fluid biomarkers for Alzheimer's disease. Alcolea D; Carmona-Iragui M; Suárez-Calvet M; Sánchez-Saudinós MB; Sala I; Antón-Aguirre S; Blesa R; Clarimón J; Fortea J; Lleó A J Alzheimers Dis; 2014; 42(1):157-67. PubMed ID: 24820015 [TBL] [Abstract][Full Text] [Related]
17. Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders. Olsson B; Portelius E; Cullen NC; Sandelius Å; Zetterberg H; Andreasson U; Höglund K; Irwin DJ; Grossman M; Weintraub D; Chen-Plotkin A; Wolk D; McCluskey L; Elman L; Shaw LM; Toledo JB; McBride J; Hernandez-Con P; Lee VM; Trojanowski JQ; Blennow K JAMA Neurol; 2019 Mar; 76(3):318-325. PubMed ID: 30508027 [TBL] [Abstract][Full Text] [Related]
18. Prediction of P-tau/Aβ42 in the cerebrospinal fluid with blood microRNAs in Alzheimer's disease. Jia L; Zhu M; Yang J; Pang Y; Wang Q; Li Y; Li T; Li F; Wang Q; Li Y; Wei Y BMC Med; 2021 Nov; 19(1):264. PubMed ID: 34775974 [TBL] [Abstract][Full Text] [Related]
19. Correlations between serum and CSF pNfH levels in ALS, FTD and controls: a comparison of three analytical approaches. Wilke C; Pujol-Calderón F; Barro C; Stransky E; Blennow K; Michalak Z; Deuschle C; Jeromin A; Zetterberg H; Schüle R; Höglund K; Kuhle J; Synofzik M Clin Chem Lab Med; 2019 Sep; 57(10):1556-1564. PubMed ID: 31251725 [TBL] [Abstract][Full Text] [Related]
20. Comparisons of clinical symptoms in biomarker-confirmed Alzheimer's disease, dementia with Lewy bodies, and frontotemporal dementia patients in a local memory clinic. Shea YF; Ha J; Chu LW Psychogeriatrics; 2015 Dec; 15(4):235-41. PubMed ID: 25533477 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]